TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate

Human Pathology

Volumn 42, Issue 1, 2011, Pages 11-17

  Guo, Charles C ^a   Dancer, Jane Y ^a   Wang, Yan ^a   Aparicio, Ana ^a   Navone, Nora M ^a   Troncoso, Patricia ^a   Czerniak, Bogdan A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Mouse xenograft; Prostate cancer; Small cell carcinoma; TMPRSS2 ERG gene fusion

Indexed keywords

DNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CARCINOMA; DNA SEQUENCE; EXON; FUSION GENE; GENE DELETION; GENE FUSION; HUMAN; LUNG SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; PROSTATE SMALL CELL CARCINOMA; SEQUENCE ANALYSIS; SMALL CELL CARCINOMA; TMPRSS2 ERG FUSION GENE; TUMOR XENOGRAFT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, SMALL CELL; GENE FUSION; HUMANS; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEINS, FUSION; PROSTATE; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES; TRANSPLANTATION, HETEROLOGOUS; URINARY BLADDER NEOPLASMS;

EID: 78649987427     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.05.026     Document Type: Article

References (27)

1. Palmgren J.S., Karavadia S.S., and Wakefield M.R. Unusual and underappreciated: small cell carcinoma of the prostate Semin Oncol 34 2007 22 29
2. Spiess P.E., Pettaway C.A., and Vakar-Lopez F. Treatment outcomes of small cell carcinoma of the prostate: a single-center study Cancer 110 2007 1729 1737
3. Stein M.E., Bernstein Z., and Abacioglu U. Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications-a retrospective study of 30 patients from the rare cancer network Am J Med Sci 336 2008 478 488
4. Nicholson S.A., Beasley M.B., and Brambilla E. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens Am J Surg Pathol 26 2002 1184 1197
5. Wang W., and Epstein J.I. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases Am J Surg Pathol 32 2008 65 71
6. Yao J.L., Madeb R., and Bourne P. Small cell carcinoma of the prostate: an immunohistochemical study Am J Surg Pathol 30 2006 705 712
7. Tomlins S.A., Rhodes D.R., and Perner S. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648
8. Tomlins S.A., Mehra R., and Rhodes D.R. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer Cancer Res 66 2006 3396 3400
9. Wang J., Cai Y., and Ren C. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer Cancer Res 66 2006 8347 8351
10. Attard G., Clark J., and Ambroisine L. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer Oncogene 27 2008 253 263
11. Clark J., Merson S., and Jhavar S. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate Oncogene 26 2007 2667 2673
12. Helgeson B.E., Tomlins S.A., and Shah N. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer Cancer Res 68 2008 73 80
13. Guo C.C., Zuo G., and Cao D. Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion Mod Pathol 22 2009 866 871
14. Li Z.G., Mathew P., and Yang J. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms J Clin Invest 118 2008 2697 2710
15. Abrahamsson P.A. Neuroendocrine differentiation in prostatic carcinoma Prostate 39 1999 135 148
16. Schron D.S., Gipson T., and Mendelsohn G. The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study Cancer 53 1984 2478 2480
17. Helpap B., and Köllermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis Virchows Arch 434 1999 385 391
18. Ordóñez N.G. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas Am J Surg Pathol 24 2000 1217 1223
19. Simon R.A., di Sant'Agnese P.A., and Huang L.S. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers Hum Pathol 40 2009 252 258
20. Demichelis F., Fall K., and Perner S. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort Oncogene 26 2007 4596 4599
21. Mehra R., Tomlins S.A., and Yu J. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer Cancer Res 68 2008 3584 3590
22. Perner S., Mosquera J.M., and Demichelis F. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion Am J Surg Pathol 31 2007 882 888
23. Gopalan A., Leversha M.A., and Satagopan J.M. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy Cancer Res 69 2009 1400 1406
24. Han B., Mehra R., and Suleman K. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma Mod Pathol 2009 [E-pub ahead of print], PMID: 19465903
25. van Weerden W.M., and Romijn J.C. Use of nude mouse xenograft models in prostate cancer research Prostate 43 2000 263 271
26. Navone N.M., Logothetis C.J., von Eschenbach A.C., and Troncoso P. Model systems of prostate cancer: uses and limitations Cancer Metastasis Rev 17 1999 361 371
27. Mertz K.D., Setlur S.R., and Dhanasekaran S.M. Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model Neoplasia 9 2007 200 206